Weston Brain Institute
14
5
6
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
14.3%
2 terminated/withdrawn out of 14 trials
50.0%
-36.5% vs industry average
7%
1 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Stem Cell Therapy for Early Alzheimer's Disease
Role: collaborator
Levetiracetam for Persons at Risk for Alzheimer's Disease
Role: collaborator
Cannabidiol Medication Intervention Trial
Role: collaborator
The GBA Multimodal Study in Parkinson's Disease
Role: collaborator
Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients
Role: collaborator
BEAM: Brain-Eye Amyloid Memory Study
Role: collaborator
Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease
Role: collaborator
Ambroxol as a Treatment for Parkinson's Disease Dementia
Role: collaborator
Intranasal Oxytocin for Frontotemporal Dementia
Role: collaborator
Subgenual Cingulate Deep Brain STIMulation for Apathetic Behavioral Variant FRONtotemporal Dementia
Role: collaborator
Establishing Alpha-synuclein RT-QuIC Assay as a Diagnostic Technique in REM Sleep Behaviour Disorder
Role: collaborator
Changes in Metabolic Activity, and Gait Function by Dual-task Cognitive Game-based Treadmill Intervention in Parkinson's Disease.
Role: collaborator
Novel Tools for the Delivery and Assessment of Exercise Programs Adapted to Individuals With Parkinson's Disease
Role: collaborator
Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration
Role: collaborator
All 14 trials loaded